Search Results - "Jamieson, Stephen"

Refine Results
  1. 1

    Mechanisms of resistance to trastuzumab emtansine (T-DM1) in HER2-positive breast cancer by Hunter, Francis W., Barker, Hilary R., Lipert, Barbara, Rothé, Françoise, Gebhart, Géraldine, Piccart-Gebhart, Martine J., Sotiriou, Christos, Jamieson, Stephen M. F.

    Published in British journal of cancer (01-03-2020)
    “…The HER2-targeted antibody–drug conjugate trastuzumab emtansine (T-DM1) is approved for the treatment of metastatic, HER2-positive breast cancer after prior…”
    Get full text
    Journal Article
  2. 2

    The CSF1 receptor inhibitor pexidartinib (PLX3397) reduces tissue macrophage levels without affecting glucose homeostasis in mice by Merry, Troy L., Brooks, Anna E. S., Masson, Stewart W., Adams, Shannon E., Jaiswal, Jagdish K., Jamieson, Stephen M. F., Shepherd, Peter R.

    Published in International Journal of Obesity (01-01-2020)
    “…Background and objectives Excessive adipose tissue macrophage accumulation in obesity has been implicated in mediating inflammatory responses that impair…”
    Get full text
    Journal Article
  3. 3

    Impact of the Halogen Substitution Pattern on the Biological Activity of Organoruthenium 8‑Hydroxyquinoline Anticancer Agents by Kubanik, Mario, Holtkamp, Hannah, Söhnel, Tilo, Jamieson, Stephen M. F, Hartinger, Christian G

    Published in Organometallics (14-12-2015)
    “…8-Hydroxyquinoline and its derivatives have a broad variety of pharmacological properties, which make them an ideal bioactive building block in the development…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Dual pH-sensitive liposomes with low pH-triggered sheddable PEG for enhanced tumor-targeted drug delivery by Kanamala, Manju, Palmer, Brian D, Jamieson, Stephen Mf, Wilson, William R, Wu, Zimei

    Published in Nanomedicine (London, England) (01-08-2019)
    “…pH-sensitive liposomes (pSL) have emerged as promising nanocarriers due to their endo/lysosome-escape abilities, however, their pH sensitivity is compromised…”
    Get full text
    Journal Article
  6. 6

    Calcium Enabled Remote Loading of a Weak Acid Into pH-sensitive Liposomes and Augmented Cytosolic Delivery to Cancer Cells via the Proton Sponge Effect by Yang, Mimi M., Yarragudi, Sasi Bhushan, Jamieson, Stephen M. F., Tang, Mingtan, Wilson, William R., Wu, Zimei

    Published in Pharmaceutical research (01-06-2022)
    “…While delivery of chemotherapeutics to cancer cells by nanomedicines can improve therapeutic outcomes, many fail due to the low drug loading (DL), poor…”
    Get full text
    Journal Article
  7. 7

    Mustards-Derived Terpyridine–Platinum Complexes as Anticancer Agents: DNA Alkylation vs Coordination by Adams, Muneebah, Sullivan, Matthew P, Tong, Kelvin K. H, Goldstone, David C, Hanif, Muhammad, Jamieson, Stephen M. F, Hartinger, Christian G

    Published in Inorganic chemistry (15-02-2021)
    “…The development of bifunctional platinum complexes with the ability to interact with DNA via different binding modes is of interest in anticancer metallodrug…”
    Get full text
    Journal Article
  8. 8

    Targeting growth hormone in cancer: future perspectives by Wang, Yue, Jamieson, Stephen M F, Perry, Jo K

    Published in Endocrine-related cancer (01-09-2023)
    “…Decades of published research support a role for growth hormone (GH) in cancer. Accordingly, there is increasing interest in targeting GH in oncology, with GH…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Growth hormone receptor antagonism suppresses tumour regrowth after radiotherapy in an endometrial cancer xenograft model by Evans, Angharad, Jamieson, Stephen M.F, Liu, Dong-Xu, Wilson, William R, Perry, Jo K

    Published in Cancer letters (28-08-2016)
    “…Highlights • The GH receptor is a potential target for anticancer therapy. • We demonstrate that pegvisomant combined with radiation significantly delayed the…”
    Get full text
    Journal Article
  11. 11

    Anti‐Inflammatory Oxicams as Multi‐donor Ligand Systems: pH‐ and Solvent‐Dependent Coordination Modes of Meloxicam and Piroxicam to Ru and Os by Aman, Farhana, Hanif, Muhammad, Kubanik, Mario, Ashraf, Adnan, Söhnel, Tilo, Jamieson, Stephen M. F., Siddiqui, Waseeq Ahmad, Hartinger, Christian G.

    Published in Chemistry : a European journal (06-04-2017)
    “…The nitrogen‐ and sulfur‐containing 1,2‐benzothiazines meloxicam and piroxicam are widely used as nonsteroidal anti‐inflammatory drugs. Intrigued by the…”
    Get full text
    Journal Article
  12. 12

    Next-Generation Hypoxic Cell Radiosensitizers: Nitroimidazole Alkylsulfonamides by Bonnet, Muriel, Hong, Cho Rong, Wong, Way Wua, Liew, Lydia P, Shome, Avik, Wang, Jingli, Gu, Yongchuan, Stevenson, Ralph J, Qi, Wen, Anderson, Robert F, Pruijn, Frederik B, Wilson, William R, Jamieson, Stephen M. F, Hicks, Kevin O, Hay, Michael P

    Published in Journal of medicinal chemistry (08-02-2018)
    “…Innovations in the field of radiotherapy such as stereotactic body radiotherapy, along with the advent of radio-immuno-oncology, herald new opportunities for…”
    Get full text
    Journal Article
  13. 13

    Clinical relevance and therapeutic predictive ability of hypoxia biomarkers in head and neck cancer tumour models by Lee, Tet Woo, Singleton, Dean C., Harms, Julia K., Lu, Man, McManaway, Sarah P., Lai, Amy, Tercel, Moana, Pruijn, Frederik B., Macann, Andrew M. J., Hunter, Francis W., Wilson, William R., Jamieson, Stephen M. F.

    Published in Molecular oncology (01-08-2024)
    “…Tumour hypoxia promotes poor patient outcomes, with particularly strong evidence for head and neck squamous cell carcinoma (HNSCC). To effectively target…”
    Get full text
    Journal Article
  14. 14

    Genetic Code Expansion Enables Site-Specific PEGylation of a Human Growth Hormone Receptor Antagonist through Click Chemistry by Tamshen, Kyle, Wang, Yue, Jamieson, Stephen M. F, Perry, Jo K, Maynard, Heather D

    Published in Bioconjugate chemistry (16-09-2020)
    “…Regulation of human growth hormone (GH) signaling has important applications in the remediation of several diseases including acromegaly and cancer. Growth…”
    Get full text
    Journal Article
  15. 15

    Hydroxyquinoline-derived anticancer organometallics: Introduction of amphiphilic PTA as an ancillary ligand increases their aqueous solubility by Tremlett, William D.J., Tong, Kelvin K.H., Steel, Tasha R., Movassaghi, Sanam, Hanif, Muhammad, Jamieson, Stephen M.F., Söhnel, Tilo, Hartinger, Christian G.

    Published in Journal of inorganic biochemistry (01-10-2019)
    “…Organometallic compounds based on bioactive ligand systems have shown promising antiproliferative properties. The use of 8-hydroxyquinoline and its derivatives…”
    Get full text
    Journal Article
  16. 16

    Anthracenyl Functionalization of Half-Sandwich Carbene Complexes: In Vitro Anticancer Activity and Reactions with Biomolecules by Lee, Betty Y. T, Sullivan, Matthew P, Yano, Ena, Tong, Kelvin K. H, Hanif, Muhammad, Kawakubo-Yasukochi, Tomoyo, Jamieson, Stephen M. F, Soehnel, Tilo, Goldstone, David C, Hartinger, Christian G

    Published in Inorganic chemistry (04-10-2021)
    “…N-Heterocyclic carbene (NHC) ligands are widely investigated in medicinal inorganic chemistry. Here, we report the preparation and characterization of a series…”
    Get full text
    Journal Article
  17. 17

    Clonal dynamics limits detection of selection in tumour xenograft CRISPR/Cas9 screens by Lee, Tet Woo, Hunter, Francis W., Tsai, Peter, Print, Cristin G., Wilson, William R., Jamieson, Stephen M. F.

    Published in Cancer gene therapy (01-12-2023)
    “…Transplantable in vivo CRISPR/Cas9 knockout screens, in which cells are edited in vitro and inoculated into mice to form tumours, allow evaluation of gene…”
    Get full text
    Journal Article
  18. 18

    Anticancer activity of Ru- and Os(arene) compounds of a maleimide-functionalized bioactive pyridinecarbothioamide ligand by Hanif, Muhammad, Moon, Sally, Sullivan, Matthew P., Movassaghi, Sanam, Kubanik, Mario, Goldstone, David C., Söhnel, Tilo, Jamieson, Stephen M.F., Hartinger, Christian G.

    Published in Journal of inorganic biochemistry (01-12-2016)
    “…With the aim of increasing the accumulation of Ru anticancer agents in the tumor, a targeted delivery strategy based on a maleimide anchor for the biological…”
    Get full text
    Journal Article
  19. 19

    In vitro and in vivo accumulation of the anticancer Ru complexes [RuII(cym)(HQ)Cl] and [RuII(cym)(PCA)Cl]Cl by Riisom, Mie, Morrow, Stuart J., Herbert, Caitlin D., Tremlett, William D. J., Astin, Jonathan W., Jamieson, Stephen M. F., Hartinger, Christian G.

    Published in Journal of biological inorganic chemistry (01-12-2023)
    “…The cellular accumulation and the underlying mechanisms for the two ruthenium-based anticancer complexes [Ru II (cym)(HQ)Cl] 1 (cym = η 6 - p -cymene, HQ =…”
    Get full text
    Journal Article
  20. 20

    Impact of Coordination Mode and Ferrocene Functionalization on the Anticancer Activity of N‑Heterocyclic Carbene Half-Sandwich Complexes by Tong, Kelvin K. H., Riisom, Mie, Leung, Euphemia, Hanif, Muhammad, Söhnel, Tilo, Jamieson, Stephen M. F., Hartinger, Christian G.

    Published in Inorganic chemistry (31-10-2022)
    “…The substitution of phenyl rings in established drugs with ferrocenyl moieties has been reported to yield compounds with improved biological activity and…”
    Get full text
    Journal Article